Circulating and muscle-specific IGF-1 levels are reduced in animal models of cancer cachexia (e.g., AH-130 hepatoma and C26 colon adenocarcinoma), correlating with the loss of muscle mass [306]. Here, IGF1 is linked to Cachexia.